(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CARBAMATOS DE PIRAZINA, SUA COMPOSIÇÃO FARMACÊUTICA E SEUS USOS COMO MODULADORES DO RECEPTOR DE GLUN2B

ArquivadaInvention PatentPCT · EP2020066396

Application data

Number

112021023562

Type

Invention Patent

Filing

06/12/2020

Publication

01/04/2022

PCT

EP2020066396

Progress at the INPI

  1. Filing06/12/20
  2. Publication01/04/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/24/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANSSEN PHARMACEUTICA N.V.

BE

See this company's full portfolio

Inventors

C. G. (pessoa física)

US

Technical data

Priority claims

US

62/861,642 · 06/14/2019

Abstract

CARBAMATOS DE PIRAZINA E SEUS USOS COMO MODULADORES DO RECEPTOR DE GLUN2B. A presente invenção refere-se a carbamatos de piridina, composições farmacêuticas contendo carbamatos de piridina e usos dos carbamatos de piridina e das composições farmacêuticas para modular os receptores de GluN2B e tratar doenças, distúrbios e condições médicas mediados pela atividade do receptor de GluN2B.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

09/24/2024

RPI 2803

Parecer de pré-exame

#6.23

06/11/2024

RPI 2788

Notificação de entrada na fase nacional - PCT

#1.3

01/04/2022

RPI 2661

Alteração de dados cadastrais

#1.1

11/30/2021

RPI 2656

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.